These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 12151737

  • 21. Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus.
    Przepiorka D, Ippoliti C, Khouri I, Anderlini P, Mehra R, Giralt S, Gajewski J, Fritsche H, Deisseroth AB, Cleary K, Champlin R, van Besien K, Andersson B, Korbling M.
    Transplantation; 1996 Dec 27; 62(12):1806-10. PubMed ID: 8990368
    [Abstract] [Full Text] [Related]

  • 22. Methotrexate vs Cyclosporin A as a single agent for graft-versus-host disease prophylaxis in pediatric patients with hematological malignancies undergoing allogeneic bone marrow transplantation from HLA-identical siblings: a single-center analysis in Japan.
    Koga Y, Nagatoshi Y, Kawano Y, Okamura J.
    Bone Marrow Transplant; 2003 Jul 27; 32(2):171-6. PubMed ID: 12838282
    [Abstract] [Full Text] [Related]

  • 23. Microangiopathy following allogeneic marrow transplantation. Association with cyclosporine and methylprednisolone for graft-versus-host disease prophylaxis.
    Kalhs P, Brugger S, Schwarzinger I, Greinix HT, Keil F, Kyrle PA, Knöbl P, Schneider B, Höcker P, Linkesch W.
    Transplantation; 1995 Nov 15; 60(9):949-57. PubMed ID: 7491699
    [Abstract] [Full Text] [Related]

  • 24. Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxis.
    Byrne JL, Stainer C, Hyde H, Miflin G, Haynes AP, Bessell EM, Russell NH.
    Bone Marrow Transplant; 1998 Sep 15; 22(6):541-5. PubMed ID: 9758340
    [Abstract] [Full Text] [Related]

  • 25. Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation.
    Przepiorka D, Ippoliti C, Khouri I, Woo M, Mehra R, Le Bherz D, Giralt S, Gajewski J, Fischer H, Fritsche H, Deisseroth AB, Cleary K, Champlin R, Besien K, Andersson B, Maher R, Fitzsimmons W.
    Blood; 1996 Dec 01; 88(11):4383-9. PubMed ID: 8943876
    [Abstract] [Full Text] [Related]

  • 26. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
    Herrera C, Torres A, García-Castellano JM, Roman J, Martin C, Serrano J, Falcon M, Alvarez MA, Gomez P, Martinez F.
    Bone Marrow Transplant; 1999 Mar 01; 23(5):443-50. PubMed ID: 10100557
    [Abstract] [Full Text] [Related]

  • 27. Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial.
    Deeg HJ, Lin D, Leisenring W, Boeckh M, Anasetti C, Appelbaum FR, Chauncey TR, Doney K, Flowers M, Martin P, Nash R, Schoch G, Sullivan KM, Witherspoon RP, Storb R.
    Blood; 1997 May 15; 89(10):3880-7. PubMed ID: 9160697
    [Abstract] [Full Text] [Related]

  • 28. [CD25 monoclonal antibody for GVHD prophylaxis in non-T-cell depleted haploidentical bone marrow transplantation for treatment of childhood leukemia].
    Chen HR, Ji SQ, Yan HM, Wang HX, Liu J, Xue M, Zhu L.
    Zhonghua Er Ke Za Zhi; 2004 Apr 15; 42(4):294-8. PubMed ID: 15157394
    [Abstract] [Full Text] [Related]

  • 29. Do corticosteroids add any benefit to standard GVHD prophylaxis in allogeneic BMT?
    Ancín I, Ferrá C, Gallardo D, Peris J, Berlanga J, Gonzalez JR, Virgili N, Grañena A.
    Bone Marrow Transplant; 2001 Jul 15; 28(1):39-45. PubMed ID: 11498742
    [Abstract] [Full Text] [Related]

  • 30. Comparison of Tacrolimus and Cyclosporine Combined With Methotrexate for Graft Versus Host Disease Prophylaxis After Allogeneic Hematopoietic Cell Transplantation.
    Huang B, Lin X, Zhang Z, Zhang Y, Zheng Z, Zhong C, He X, Chen M.
    Transplantation; 2020 Feb 15; 104(2):428-436. PubMed ID: 31283681
    [Abstract] [Full Text] [Related]

  • 31. Tacrolimus and methotrexate for the prophylaxis of acute graft-versus-host disease in allogeneic bone marrow transplantation in patients with hematologic malignancies.
    Uberti JP, Silver SM, Adams PT, Jacobson P, Scalzo A, Ratanatharathorn V.
    Bone Marrow Transplant; 1997 Jun 15; 19(12):1233-8. PubMed ID: 9208118
    [Abstract] [Full Text] [Related]

  • 32. Graft-versus-host disease prophylaxis with anti-T-cell monoclonal antibody OKT3, prednisone and methotrexate in allogeneic bone-marrow transplantation.
    Filipovich AH, Krawczak CL, Kersey JH, McGlave P, Ramsay NK, Goldman A, Goldstein G.
    Br J Haematol; 1985 May 15; 60(1):143-52. PubMed ID: 3890926
    [Abstract] [Full Text] [Related]

  • 33. Low-dose cyclosporin A with short-term methotrexate for graft-versus-host disease prophylaxis in allogeneic bone marrow transplantation from human leukocyte antigen-identical siblings: a prospective phase II study in Japanese patients.
    Kohno A, Morishita Y, Iida H, Sakamaki H, Yokozawa T, Kitaori K, Ozeki K, Matsuo K, Sao H.
    Int J Hematol; 2006 Jul 15; 84(1):83-9. PubMed ID: 16867909
    [Abstract] [Full Text] [Related]

  • 34. Lack of interaction between tacrolimus (FK506) and methotrexate in bone marrow transplant recipients.
    Wingard JR, Nash RA, Ratanatharathorn V, Fay JW, Klein JL, Przepiorka D, Maher RM, Devine SM, Boswell G, Bekersky I, Fitzsimmons W.
    Bone Marrow Transplant; 1997 Jul 15; 20(1):49-51. PubMed ID: 9232256
    [Abstract] [Full Text] [Related]

  • 35. Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation.
    Van Lint MT, Uderzo C, Locasciulli A, Majolino I, Scimé R, Locatelli F, Giorgiani G, Arcese W, Iori AP, Falda M, Bosi A, Miniero R, Alessandrino P, Dini G, Rotoli B, Bacigalupo A.
    Blood; 1998 Oct 01; 92(7):2288-93. PubMed ID: 9746766
    [Abstract] [Full Text] [Related]

  • 36. A comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis, stratified by stem cell source: a retrospective nationwide survey.
    Sakai R, Taguri M, Oshima K, Mori T, Ago H, Adachi S, Morita S, Taniguchi S, Fukuda T, Ohashi K, Eto T, Miyamura K, Iwato K, Kobayashi N, Kanamori H, Morishima Y, Nagamura-Inoue T, Sakamaki H, Atsuta Y, Murata M.
    Int J Hematol; 2016 Mar 01; 103(3):322-33. PubMed ID: 26800676
    [Abstract] [Full Text] [Related]

  • 37. Tacrolimus (FK506) and methotrexate regimens to prevent graft-versus-host disease after unrelated dog leukocyte antigen (DLA) nonidentical marrow transplantation.
    Yu C, Storb R, Deeg HJ, Graham TC, Scheuning FG, Huss R, Seidel K, Fitzsimmons WE.
    Bone Marrow Transplant; 1996 Apr 01; 17(4):649-53. PubMed ID: 8722370
    [Abstract] [Full Text] [Related]

  • 38. FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation.
    Fay JW, Wingard JR, Antin JH, Collins RH, Piñeiro LA, Blazar BR, Saral R, Bierer BE, Przepiorka D, Fitzsimmons WE, Maher RM, Weisdorf DJ.
    Blood; 1996 Apr 15; 87(8):3514-9. PubMed ID: 8605372
    [Abstract] [Full Text] [Related]

  • 39. [Combination of mycophenolate mofetil with cyclosporine A and methotrexate as acute GVHD prophylaxis after unrelated donor allogeneic bone marrow transplantation].
    Huang H, Lin M, Meng H, Qian W, Jin J, Huang J, Luo Y.
    Zhonghua Xue Ye Xue Za Zhi; 2001 Feb 15; 22(2):76-8. PubMed ID: 11877053
    [Abstract] [Full Text] [Related]

  • 40. Minimum-Dose, Short-Term Methotrexate With Tacrolimus for Graft-vs-Host Disease Prophylaxis Following Unrelated Cord Blood Transplantation in Adults: A Retrospective Analysis at a Single Institution.
    Iino M, Sato T, Sakamoto Y.
    Transplant Proc; 2021 Feb 15; 53(1):396-404. PubMed ID: 33308840
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.